PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40121C00109Strengthening pharmacovigilance systems and — University of California, Los Angeles

University of California, Los Angeles holds $56.1M across 151 federal awards, concentrated at National Aeronautics and Space Administration (NASA). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs

Awarding office

University of California, Los Angeles

Recipient

Sep 30, 2026

PoP end

$2.8M

Obligated

$2.8M

Potential

541714

NAICS

AN11

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs University of California, Los Angeles — $90

Contract facts

NONE

Contract number75F40121C00109

AgencyFda Office Of Acq Grant Svcs

Awarding officeFda Office Of Acq Grant Svcs

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentUniversity of California, Los Angeles

CAGE4B557

UEIRN64EPNH8JC6

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN11

Place of performanceSILVER SPRING MD

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

Related solicitationFDABAA-21-00123

PoP startAug 27, 2021

PoP end (current)Sep 30, 2026

Obligated$2.8M

Current value$2.8M

Potential value$2.8M

STRENGTHENING PHARMACOVIGILANCE SYSTEMS AND ADVERSE EVENTS REPORTING FOR MATERNAL IMMUNIZATION SAFETY IN THE DEMOCRATIC REPUBLIC OF CONGO - BAA GLOBWP 60 is a federal NONE award for Fda Office Of Acq Grant Svcs held by University of California, Los Angeles. Estimated value $2.8M ($2.8M obligated). Current period of performance ends Sep 30, 2026. Last award drew 1 bidder. Place of performance: SILVER SPRING MD. Related solicitation FDABAA-21-00123.

STRENGTHENING PHARMACOVIGILANCE SYSTEMS AND ADVERSE EVENTS REPORTING FOR MATERNAL IMMUNIZATION SAFETY IN THE DEMOCRATIC REPUBLIC OF CONGO - BAA GLOBWP 60

Recompete timing

Public

● Expiring in 40 days

Current PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

University of California, Los Angeles — $56.1M obligated across 151 awards (firm-wide, all agencies) · lead buyer National Aeronautics and Space Administration (NASA).

% of firm-wide obligated ($56.1M) · all agencies · Top 4 shown (95%); remaining ~5% is other agencies.

National Aeronautics and Space Administration (NASA)$23.9M · 43%Department of Health and Human Services (HHS)$21.6M · 39%Department of Defense (DOD)$4.3M · 8%Department of Veterans Affairs (VA)$3.3M · 6%

Open full company profile →

Related awards

Same incumbent

36C26221C0101

EO14042 - DATABASE SYSTEMS

$335K

Aug 31, 2026

36C24E22N0011

RESEARCH SUPPORT SERVICES

$188K

Aug 31, 2026

36C24E25N0230

UCLA CCN FMRI SERVICE CONTRACT

$112K

Aug 31, 2026

36C24E25N0258

RESEARCH ASSISTANCE SERVICES

$195K

Sep 14, 2026

W912HQ22C0086

SERDP PROJECT ER-2713 FOLLOW ON

$1.0M

Sep 27, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75F40121C00109?

75F40121C00109 (Strengthening pharmacovigilance systems and) is a Fda Office Of Acq Grant Svcs award with a potential value of $2.8M, currently held by University of California, Los Angeles. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40121C00109?

Fda Office Of Acq Grant Svcs awarded 75F40121C00109 to University of California, Los Angeles (potential $2.8M).

Who is the incumbent on 75F40121C00109?

University of California, Los Angeles is the incumbent with $56.1M across 151 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does University of California, Los Angeles’s 75F40121C00109 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Mar 3, 2026